Department of Nutritional Sciences, King's College London, London, UK.
Department of Nutrition and Dietetics, Guy's and St Thomas' NHS Foundation Trust, London, UK.
J Hum Nutr Diet. 2025 Feb;38(1):e13393. doi: 10.1111/jhn.13393. Epub 2024 Nov 5.
The dietary restriction of fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAPs), called the low-FODMAP diet (LFD), is frequently used to manage irritable bowel syndrome (IBS). This service evaluation aimed to assess the long-term effectiveness of the LFD in managing IBS symptoms and whether symptom response and dietary adherence to the LFD were associated.
This observational service evaluation collected data via questionnaires during clinical dietetic appointments for IBS management. Symptom severity was reported at baseline, short term (following FODMAP restriction) and long term (following FODMAP reintroduction). Additional data that captured experiences following the LFD were collected at long-term follow-up.
Of 184 patients, 14% reported satisfactory relief from global symptoms at baseline, which increased to 69% at short-term follow-up and 57% at long-term follow-up (p < 0.001). The most notable improvements in individual symptoms between baseline and long-term follow-up were abdominal bloating (72% baseline, 48% long term, p < 0.001), abdominal pain (61% baseline, 30% long term, p < 0.001) and flatulence (71% baseline, 40% long term, p < 0.001). High adherence with the LFD at short-term follow-up was not associated with long-term symptom improvement, but there was an association between long-term adherence and global symptom severity (p = 0.032). Completion of FODMAP reintroduction as per protocol was associated with long-term symptom improvement (p = 0.049).
The LFD is an effective treatment for managing IBS symptoms in the long term, particularly, when the diet is adhered to and reintroduction is completed as per dietetic education. Further randomised-controlled trials are required to explore the cause-and-effect relationship between LFD and IBS symptom management.
限制可发酵的低聚糖、双糖、单糖和多元醇(FODMAPs)的饮食,即低 FODMAP 饮食(LFD),常用于治疗肠易激综合征(IBS)。本服务评估旨在评估 LFD 长期管理 IBS 症状的有效性,以及症状反应和对 LFD 的饮食依从性是否相关。
这项观察性服务评估通过 IBS 管理的临床饮食咨询期间的问卷调查收集数据。在基线、短期(FODMAP 限制后)和长期(FODMAP 再引入后)报告症状严重程度。在长期随访时收集了捕获 LFD 后经验的其他数据。
在 184 名患者中,14%的患者报告在基线时对整体症状有满意的缓解,短期随访时增加到 69%,长期随访时增加到 57%(p<0.001)。个体症状在基线和长期随访之间最显著的改善是腹部肿胀(72%基线,48%长期,p<0.001)、腹痛(61%基线,30%长期,p<0.001)和呃气(71%基线,40%长期,p<0.001)。短期随访时对 LFD 的高依从性与长期症状改善无关,但长期依从性与整体症状严重程度有关(p=0.032)。按照方案完成 FODMAP 再引入与长期症状改善有关(p=0.049)。
LFD 是长期管理 IBS 症状的有效治疗方法,特别是当饮食得到遵守且按照饮食教育完成再引入时。需要进一步的随机对照试验来探索 LFD 与 IBS 症状管理之间的因果关系。